{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Zhu X"],"funding":["Provincial College Students Innovation Training Program of Central South University","Changsha Science and Technology Bureau Scientific Research Project"],"pagination":["336"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9541013"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["20(1)"],"pubmed_abstract":["<h4>Background</h4>TIMM8A is a protein-coding gene located on the X chromosome. There is evidence that TIMM8A plays an important role in mitochondrial morphology and fission. Studies have shown that mitophagy and fission could affect the function of immune cells. However, there is currently no research on this gene's role in cancer occurrence and progression.<h4>Methods</h4>TIMM8A expression was analyzed via the Tumor Immune Estimation Resource (TIMER) site and UALCAN database. We evaluated the influence of TIMM8A on clinical prognosis using Kaplan-Meier plotter, the PrognoScan database, and Human Protein Atlas (HPA). The correlations between TIMM8A and cancer immune infiltrates were investigated via TIMER. Tumor Immune Dysfunction and Exclusion (TIDE) was used to evaluate the potential of"],"journal":["World journal of surgical oncology"],"pubmed_title":["TIMM8A is associated with dysfunction of immune cell in BRCA and UCEC for predicting anti-PD-L1 therapy efficacy."],"pmcid":["PMC9541013"],"funding_grant_id":["S2021105330737","Kq2004155"],"pubmed_authors":["Cheng S","Liao Y","Wu Z","Zhou D","Zhu X","Wang H","Yuan Z"],"additional_accession":[]},"is_claimable":false,"name":"TIMM8A is associated with dysfunction of immune cell in BRCA and UCEC for predicting anti-PD-L1 therapy efficacy.","description":"<h4>Background</h4>TIMM8A is a protein-coding gene located on the X chromosome. There is evidence that TIMM8A plays an important role in mitochondrial morphology and fission. Studies have shown that mitophagy and fission could affect the function of immune cells. However, there is currently no research on this gene's role in cancer occurrence and progression.<h4>Methods</h4>TIMM8A expression was analyzed via the Tumor Immune Estimation Resource (TIMER) site and UALCAN database. We evaluated the influence of TIMM8A on clinical prognosis using Kaplan-Meier plotter, the PrognoScan database, and Human Protein Atlas (HPA). The correlations between TIMM8A and cancer immune infiltrates were investigated via TIMER. Tumor Immune Dysfunction and Exclusion (TIDE) was used to evaluate the potential of","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Oct","modification":"2025-04-22T05:43:14.467Z","creation":"2024-11-12T04:00:44.324Z"},"accession":"S-EPMC9541013","cross_references":{"pubmed":["36207751"],"doi":["10.1186/s12957-022-02736-6"]}}